跳至主要内容
临床试验/ACTRN12622000462785
ACTRN12622000462785终止未知

A double-blinded randomised placebo controlled pilot study investigating impact of a dairy based protein complex (IDP) on immune responses after influenza vaccination, in healthy subjects

Quantec Ltd0 个研究点目标入组 53 人开始时间: 2022年3月24日最近更新:
适应症

试验速览

阶段
未知
状态
终止
发起方
入组人数
53

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
25 Years 至 62 Years(—)
性别
All

入选标准

  • Age: 25-62 years of age
  • Sex: Female and male
  • Health: Healthy as gauged by self-assessment and not having any chronic inflammatory conditions
  • Agreement: Participants have given written informed consent to the study.
  • Able to speak and read English

排除标准

  • Lactose intolerance; known or suspected allergy to dairy products, starch, gluten or artificial sweeteners;
  • Participation in another clinical trial;
  • Pregnancy or currently lactating; have had flu vaccination recently;
  • Had anaphylaxis reaction to influenza vaccination;
  • Had already received the influenza vaccination in 2022;
  • Had a recent cold (three weeks prior to the first visit);
  • Have any chronic inflammatory conditions.

研究者

发起方
Quantec Ltd

相似试验

Pilot study: Can a dairy based protein (IDP) enhance... | 临床试验